A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HGP1602 in Healthy Subjects
Clinical trial NCT04084184 · COMPLETED
Trial details
- NCT number
- NCT04084184
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-15
- Primary completion
- 2019-03-25
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.